Lycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model

dc.contributor.authorŞahin, Kazım
dc.contributor.authorCross, Brian
dc.contributor.authorŞahin, Nurhan
dc.contributor.authorCiccone, Karina
dc.contributor.authorSuleiman, Shadeah
dc.contributor.authorOsunkoya, Adeboye O.
dc.contributor.authorKüçük, Ömer
dc.date.accessioned2026-08-12T17:32:32Z
dc.date.issued2015
dc.departmentFırat Üniversitesi
dc.description.abstractRenal cell carcinoma (RCC) is the most frequent upper urinary tract cancer in humans and accounts for 80-85% of malignant renal tumors. Eker rat represents a unique animal model to study RCC since these rats develop spontaneous renal tumors and leiomyoma, which may be due to tuberous sclerosis 2 (TSC2) mutation resulting in the activation of the mammalian target of rapamycin (mTOR) pathway. This study examines the role of a lycopene-rich diet in the development of RCC in the TSC2 mutant Eker rat model. Ten-week old female Eker rats (n = 90) were assigned in equal numbers to receive 0, 100 or 200 mg/kg of lycopene as part of their daily diet. After 18 months the rats were sacrificed and the kidneys were removed. Immunohistochemical staining with antibodies against mTOR, phospho-S6 and EGFR were performed, as well as hematoxylin-eosin staining for histologic examination of the tumors. Tumors were counted and measured in individual kidneys. Presence of tumor decreased from 94% in control animals to 65% in the experimental group, but the difference was not statistically significant (P < 0.12). However, mean numbers of renal carcinomas were statistically significantly decreased in the lycopene-treated rats (P < 0.008) when compared to untreated controls. In the lycopene group, tumor numbers decreased (P < 0.002) and the numbers tended to decrease linearly (P < 0.003) as supplemental lycopene increased from 0 to 200. Control rats fed only basal diet had a greater length of tumors (23.98 mm) than rats fed lycopene supplement groups (12.90 mm and 11.07 mm) (P < 0.05). Moreover tumor length decreased (P < 0.02) and tumor length tended to decrease linearly (P < 0.03) as supplemental lycopene increased from 0 to 200 mg/kg. All tumors showed strong staining with antibodies against mTOR, phospho-S6 and EGER. In conclusion, dietary supplementation with lycopene attenuates the development of renal cell cancers in the predisposed TSC2 mutant Eker rat model. These results suggest that lycopene may play a role in the prevention of RCC. (C) 2015 Elsevier Inc. All rights reserved.
dc.description.sponsorshipDSM, Basel, Switzerland; Georgia Cancer Coalition Carpenter Fellowship Fund (Karma Ciccone)
dc.description.sponsorshipThis research was supported in part by funds from DSM, Basel, Switzerland, and Georgia Cancer Coalition Carpenter Fellowship Fund (Karma Ciccone). Dr. Omer Kucuk is a Georgia Cancer Coalition Distinguished Cancer Scholar.
dc.identifier.doi10.1016/j.abb.2015.01.006
dc.identifier.endpage39
dc.identifier.issn0003-9861
dc.identifier.issn1096-0384
dc.identifier.orcid0000-0002-5582-0028
dc.identifier.orcid0000-0001-9487-1154
dc.identifier.orcid0000-0001-9542-5244
dc.identifier.pmid25602702
dc.identifier.scopus2-s2.0-84932166197
dc.identifier.scopusqualityQ1
dc.identifier.startpage36
dc.identifier.urihttps://doi.org/10.1016/j.abb.2015.01.006
dc.identifier.urihttps://hdl.handle.net/11508/56665
dc.identifier.volume572
dc.identifier.wosWOS:000353368900006
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherElsevier Science Inc
dc.relation.ispartofArchives of Biochemistry and Biophysics
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/openAccess
dc.snmzKA_WoS_20260511
dc.subjectRenal cell cancer
dc.subjectLycopene
dc.subjectEker rat
dc.titleLycopene in the prevention of renal cell cancer in the TSC2 mutant Eker rat model
dc.typeArticle

Dosyalar